Cargando…
Recent Progress in Multiple Sclerosis Treatment Using Immune Cells as Targets
Multiple sclerosis (MS) is an autoimmune-mediated demyelinating disease of the central nervous system. The main pathological features are inflammatory reaction, demyelination, axonal disintegration, reactive gliosis, etc. The etiology and pathogenesis of the disease have not been clarified. The init...
Autores principales: | Ma, Xiaohong, Ma, Rong, Zhang, Mengzhe, Qian, Baicheng, Wang, Baoliang, Yang, Weijing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057470/ https://www.ncbi.nlm.nih.gov/pubmed/36986586 http://dx.doi.org/10.3390/pharmaceutics15030728 |
Ejemplares similares
-
Systematic review and meta-analysis of reflexology for people with multiple sclerosis: Systematic Review and Meta-Analysis
por: Ma, Xiaohong, et al.
Publicado: (2023) -
Progress in the Application of Drugs for the Treatment of Multiple Sclerosis
por: Wei, Weipeng, et al.
Publicado: (2021) -
Recent advances in the treatment of multiple sclerosis
por: Bennett, Jeffrey L, et al.
Publicado: (2010) -
Nanotechnology-Assisted Immunogenic Cell Death for Effective Cancer Immunotherapy
por: Guo, Yichen, et al.
Publicado: (2023) -
Targeting senescence to delay progression of multiple sclerosis
por: Oost, Wendy, et al.
Publicado: (2018)